Luttrell, Colleagues Move to Enshrine Trump's Psychedelic Therapy Order in Law, Protect Veterans' Access
Luttrell introduced legislation to codify the executive order on psychedelic treatments.

SOURCE CHECK
TAP FOR WHYTexasGOPVote is identified as a blog, and the article uses promotional language and relies mainly on statements from lawmakers involved in the bill. It provides a study reference but little independent reporting or outside scrutiny.
- Source type — A blog rather than an established news organization; partisan orientation is apparent in the presentation.
- Source diversity — Most reporting consists of statements from lawmakers promoting the legislation.
- Author attribution — No author is identified.
- Evidence — The article cites a Stanford study but gives limited detail for assessing its methods or findings.
The article identifies the bill, attributes lawmakers’ views and cites a study with specific results. It offers no independent expert perspective, opposing view or detailed context about the treatment or study.
HOW WE SCORE ↗The article is largely a favorable account of the legislation, with statements only from its supporters. The study is cited, but the article provides no countervailing expert view or discussion of limitations.
- Counterarguments presented — No objections or concerns about the bill or treatment are included.
- Source diversity — All quoted lawmakers support the legislation.
- Loaded language — Some language echoes supporters’ praise of the order and treatment rather than using detached wording.
- Omitted context — The article gives little context about the cited study or the status of the treatment.
The article presents the bill and Trump’s executive order favorably, using approving language and relying on supportive lawmakers. It does not provide critical or independent perspectives on the proposal.
- Language tone — The article repeats favorable descriptions of the policy, including claims that it could save lives and deliver lasting healing.
- Source selection — The quoted sources are lawmakers who introduced or support the legislation.
- Framing — The article frames codification as protecting progress and veterans’ access.
- Omission — No skeptical or independent perspective on the bill or treatment is included.
Rep. Morgan Luttrell and three colleagues introduced the IBOGAINE Act to put President Trump’s executive order on psychedelic treatments into law. The article cites a 2024 Stanford study reporting reductions in PTSD, depression and anxiety symptoms among participants who received ibogaine treatment.
Rep. Morgan Luttrell, alongside Reps. Lou Correa, Jack Bergman and Michael McCaul, introduced the Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy (IBOGAINE) Act. The article says the bill would codify an executive order by President Donald Trump aimed at accelerating development of and access to psychedelic drugs for serious mental illness. The lawmakers said the measure could help veterans and ensure the policy continues under future administrations.
The article says psychedelic treatments for veterans are not currently available in the United States, leading some veterans with PTSD and other mental health conditions to seek help overseas. It cites a 2024 Stanford University School of Medicine study reporting that participants who received ibogaine treatment experienced reductions of 88% in PTSD symptoms, 87% in depression symptoms and 81% in anxiety symptoms after one month.
Community verdict
9 VOTESPeople in this story
SWIPE →Representative and lead figure in introducing the IBOGAINE Act
President whose executive order the bill would codify
Representative and supporter of the IBOGAINE Act
Representative and supporter of the IBOGAINE Act
Discussion · 0
Loading comments…



